Region: European Union

The European Commission’s SEP regulation would be a geostrategic liability for the EU

Saturday Opinion: As ESTI and key US players move to intervene, the geopolitical ramifications of the proposal start to show

22 April 2023

IP could deliver a very rare Brexit dividend

With the European Commission increasingly ambivalent about patents, the UK has an opportunity to take leadership in areas such as SEP licensing and the life sciences

20 April 2023

On both sides of the Atlantic, patent policy is dictated by deep pockets not evidence

In the US and Europe, immensely wealthy businesses that use technology created by others to drive their profits have succeeded in tilting the playing field in their favour

13 April 2023

The EU is worryingly ambivalent about IP

SEP/FRAND is not the only area where the European Commission is set to propose changes that weaken the rights of innovators

08 April 2023

How the EC’s SEP licensing regulation will harm SMEs

As things stand, the only winners from the proposals will be deep pocket implementers – but there may be a way out of the mess

06 April 2023

SEP owners have a big fight on their hands to evade radical new EU regulation

Following the leak of draft rules, IAM travelled to Brussels to gauge the reaction of industry, lobbyists and lawmakers

01 April 2023

The European Commission’s SEP licensing plans are terrible on every level

Reported DG Grow proposals designed to make FRAND dealmaking in Europe more transparent, predictable and efficient are one-sided and poorly thought-through, so will do much more harm than good

30 March 2023

No such thing as ‘wait and see’ approach, warns UPC’s top judge as sunrise period begins

Court of Appeal President Klaus Grabinski speaks exclusively to IAM as three-month countdown to the Unified Patent Court gets underway

01 March 2023

The power of the unitary patent should be the UPC’s biggest draw

While the litigation system is attracting most of the attention, the new right has the potential to be more valuable than anything granted anywhere else in the world

23 February 2023

Unitary SPCs necessary to attract pharma to UPC/UP system, says Bayer IP chief

Joerg Thomaier also shares his thoughts on the UPC and EPO patent quality in an exclusive IAM interview

22 February 2023